PUBLICATION REGISTRY

Go to research.

Publikationsdata från Europe PMC och PubMed. Följ källhänvisningar från ämnesregistret till originalpublikationerna.

Publikationer som ChEBI hänvisar till för hyodeoxycholic acid. Visa hela publikationsregistret

A publication hit is not a conclusion. Publikationslistan visar bibliografiska uppgifter. Eventuella forskningsutdrag visas separat med originalunderlag. En källhänvisning visar inte i sig effekt, dosering eller säkerhet.

Publications in the selection

15 hits

Bibliografisk träff 2025-05-01

Hyodeoxycholic Acid Ameliorates Metabolic Syndrome Through Pathways of Primary Bile Acid Synthesis and Fatty Acid Degradation: Insights From a Rat Model.

Chen M, Huang K, Luo W, Zhang F, Gan H, Yang Z.

Drug Des Devel Ther · journal article · DOI 10.2147/dddt.s514189

Bibliografisk träff 2025-02-24

Acanthopanax senticosus polysaccharide alleviates LPS-induced intestinal inflammation in piglets by gut microbiota and hyodeoxycholic acid regulation.

Tao D, Dong Y, Che D, Wang Z, Zheng Y, Han R, Jiang H.

Int J Biol Macromol · journal article · DOI 10.1016/j.ijbiomac.2025.141467

Bibliografisk träff 2025-02-04

Hyodeoxycholic acid ameliorates cholestatic liver fibrosis by facilitating m<sup>6</sup>A-regulated expression of a novel anti-fibrotic target ETV4.

Xue X, Liu R, Cai Y, Gong L, Fan G, Wu J, Li X, Li X.

J Hepatol · journal article · DOI 10.1016/j.jhep.2025.01.020

Bibliografisk träff 2025-01-06

Hyodeoxycholic acid inhibits colorectal cancer proliferation through the FXR/EREG/EGFR axis.

Pang Q, Huang S, Li X, Cao J.

Front Cell Dev Biol · research-article; journal article · DOI 10.3389/fcell.2024.1480998

Bibliografisk träff 2023-09-06

Hyodeoxycholic acid ameliorates nonalcoholic fatty liver disease by inhibiting RAN-mediated PPARα nucleus-cytoplasm shuttling.

Zhong J, He X, Gao X, Liu Q, Zhao Y, Hong Y, Zhu W, Yan J, Li Y, Li Y, Zheng N, Bao Y, Wang H, Ma J, Huang W, Liu Z, Lyu Y, Ke X, Jia W, Xie C, Hu Y, Sheng L, Li H.

Nat Commun · research support, non-u.s. gov't; research-article; journal article · DOI 10.1038/s41467-023-41061-8

Bibliografisk träff 2023-08-16

Hyodeoxycholic acid alleviates non-alcoholic fatty liver disease through modulating the gut-liver axis.

Kuang J, Wang J, Li Y, Li M, Zhao M, Ge K, Zheng D, Cheung KCP, Liao B, Wang S, Chen T, Zhang Y, Wang C, Ji G, Chen P, Zhou H, Xie C, Zhao A, Jia W, Zheng X, Jia W.

Cell Metab · research support, non-u.s. gov't; journal article · DOI 10.1016/j.cmet.2023.07.011

Bibliografisk träff 2023-03-08

A Novel Drug Delivery System: Hyodeoxycholic Acid-Modified Metformin Liposomes for Type 2 Diabetes Treatment.

Hu M, Gou T, Chen Y, Xu M, Chen R, Zhou T, Liu J, Peng C, Ye Q.

Molecules · research-article; journal article · DOI 10.3390/molecules28062471

Bibliografisk träff 2020-05-08

An Integrative Pharmacology-Based Analysis of Refined Qingkailing Injection Against Cerebral Ischemic Stroke: A Novel Combination of Baicalin, Geniposide, Cholic Acid, and Hyodeoxycholic Acid.

Ma C, Wang X, Xu T, Zhang S, Liu S, Zhai C, Wang Z, Mu J, Li C, Cheng F, Wang Q.

Front Pharmacol · research-article; journal article · DOI 10.3389/fphar.2020.00519

Bibliografisk träff 2020-04-04

Hyodeoxycholic acid (HDCA) suppresses intestinal epithelial cell proliferation through FXR-PI3K/AKT pathway, accompanied by alteration of bile acids metabolism profiles induced by gut bacteria.

Song M, Yang Q, Zhang F, Chen L, Su H, Yang X, He H, Liu F, Zheng J, Ling M, Lai X, Zhu X, Wang L, Gao P, Shu G, Jiang Q, Wang S.

FASEB J · research support, non-u.s. gov't; journal article · DOI 10.1096/fj.201903244r

Bibliografisk träff 2019-11-01

Hyodeoxycholic acid protects the neurovascular unit against oxygen-glucose deprivation and reoxygenation-induced injury <i>in vitro</i>.

Li CX, Wang XQ, Cheng FF, Yan X, Luo J, Wang QG.

Neural Regen Res · research-article; journal article · DOI 10.4103/1673-5374.259617

Bibliografisk träff 2018-08-28

Fecal Hyodeoxycholic Acid Is Correlated With Tylosin-Induced Microbiome Changes in Growing Pigs.

Trudeau MP, Zhou Y, Leite FL, Gomez A, Urriola PE, Shurson GC, Chen C, Isaacson RE.

Front Vet Sci · research-article; journal article · DOI 10.3389/fvets.2018.00196

Bibliografisk träff 2013-06-11

The Human UDP-glucuronosyltransferase UGT2A1 and UGT2A2 enzymes are highly active in bile acid glucuronidation.

Perreault M, Gauthier-Landry L, Trottier J, Verreault M, Caron P, Finel M, Barbier O.

Drug Metab Dispos · research support, non-u.s. gov't; research-article; journal article · DOI 10.1124/dmd.113.052613

Bibliografisk träff 2013-06-10

Hyodeoxycholic acid improves HDL function and inhibits atherosclerotic lesion formation in LDLR-knockout mice.

Shih DM, Shaposhnik Z, Meng Y, Rosales M, Wang X, Wu J, Ratiner B, Zadini F, Zadini G, Lusis AJ.

FASEB J · research support, non-u.s. gov't; research-article; journal article; research support, n.i.h., extramural · DOI 10.1096/fj.12-223008

Bibliografisk träff 2009-09-01

Consumption of some polyphenols reduces fecal deoxycholic acid and lithocholic acid, the secondary bile acids of risk factors of colon cancer.

Han Y, Haraguchi T, Iwanaga S, Tomotake H, Okazaki Y, Mineo S, Moriyama A, Inoue J, Kato N.

J Agric Food Chem · journal article · DOI 10.1021/jf900393k

Bibliografisk träff 2008-02-29

Novel potent and selective bile acid derivatives as TGR5 agonists: biological screening, structure-activity relationships, and molecular modeling studies.

Sato H, Macchiarulo A, Thomas C, Gioiello A, Une M, Hofmann AF, Saladin R, Schoonjans K, Pellicciari R, Auwerx J.

J Med Chem · research support, non-u.s. gov't; journal article · DOI 10.1021/jm7015864